Recombinant human erythropoietin treatment may induce antithrombin-III depletion.
Arinsoy
T
T
Ozdemir
O
O
Arik
N
N
Ozcebe
O
O
Yasavul
U
U
Dündar
S
S
Turgan
C
C
Kirazli
S
S
Cağlar
S
S
D000328:Adult; D000990:Antithrombin III / Q000378:metabolism*; D004921:Erythropoietin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood; D008297:Male; D011486:Protein C / Q000378:metabolism; D011994:Recombinant Proteins / Q000009:adverse effects; D006435:Renal Dialysis
D011486:Protein C; D011994:Recombinant Proteins; D004921:Erythropoietin; D000990:Antithrombin III